Colrain Capital LLC Makes New Investment in CVS Health Co. (NYSE:CVS)

Colrain Capital LLC purchased a new position in CVS Health Co. (NYSE:CVS - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 86,350 shares of the pharmacy operator's stock, valued at approximately $3,876,000. CVS Health makes up about 3.8% of Colrain Capital LLC's holdings, making the stock its 9th biggest position.

Several other hedge funds also recently bought and sold shares of the company. Summit Financial LLC boosted its position in shares of CVS Health by 185.1% during the 4th quarter. Summit Financial LLC now owns 31,313 shares of the pharmacy operator's stock valued at $1,406,000 after acquiring an additional 20,329 shares during the last quarter. Partners in Financial Planning purchased a new position in CVS Health in the 4th quarter worth approximately $265,000. Clearbridge Investments LLC increased its holdings in shares of CVS Health by 74.1% in the 4th quarter. Clearbridge Investments LLC now owns 4,397,121 shares of the pharmacy operator's stock worth $197,387,000 after buying an additional 1,872,144 shares during the last quarter. Brandywine Global Investment Management LLC lifted its holdings in shares of CVS Health by 29.6% during the 4th quarter. Brandywine Global Investment Management LLC now owns 2,848,986 shares of the pharmacy operator's stock worth $127,891,000 after acquiring an additional 650,832 shares during the last quarter. Finally, Allianz SE purchased a new position in CVS Health in the fourth quarter worth $3,648,000. Hedge funds and other institutional investors own 80.66% of the company's stock.

Insider Buying and Selling at CVS Health

In related news, SVP James David Clark sold 7,513 shares of the stock in a transaction dated Wednesday, March 5th. The shares were sold at an average price of $66.35, for a total transaction of $498,487.55. Following the sale, the senior vice president now directly owns 8,394 shares of the company's stock, valued at approximately $556,941.90. This represents a 47.23 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Michael F. Mahoney bought 30,000 shares of CVS Health stock in a transaction on Tuesday, February 18th. The stock was acquired at an average cost of $66.70 per share, with a total value of $2,001,000.00. Following the acquisition, the director now owns 39,356 shares in the company, valued at approximately $2,625,045.20. This represents a 320.65 % increase in their position. The disclosure for this purchase can be found here. Insiders own 0.24% of the company's stock.

Remove Ads

CVS Health Trading Down 3.8 %

Shares of NYSE CVS traded down $2.60 during midday trading on Friday, hitting $64.91. 4,666,849 shares of the company traded hands, compared to its average volume of 11,510,312. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.60 and a current ratio of 0.81. CVS Health Co. has a 12-month low of $43.56 and a 12-month high of $75.27. The stock has a 50-day moving average price of $63.29 and a 200 day moving average price of $57.97. The firm has a market cap of $81.84 billion, a P/E ratio of 17.75, a P/E/G ratio of 0.98 and a beta of 0.54.

CVS Health (NYSE:CVS - Get Free Report) last announced its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. As a group, analysts expect that CVS Health Co. will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 1st. Investors of record on Tuesday, April 22nd will be paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 4.10%. The ex-dividend date of this dividend is Tuesday, April 22nd. CVS Health's payout ratio is currently 72.68%.

Analyst Ratings Changes

Several brokerages have issued reports on CVS. Leerink Partners raised CVS Health from a "market perform" rating to an "outperform" rating and lifted their price target for the stock from $55.00 to $75.00 in a research note on Thursday, February 13th. StockNews.com raised CVS Health from a "sell" rating to a "hold" rating in a research note on Thursday, February 13th. Edward Jones raised shares of CVS Health from a "hold" rating to a "buy" rating in a research note on Thursday, January 30th. Leerink Partnrs raised shares of CVS Health from a "hold" rating to a "strong-buy" rating in a report on Wednesday, February 12th. Finally, Barclays boosted their price target on shares of CVS Health from $71.00 to $73.00 and gave the stock an "overweight" rating in a research note on Thursday, February 13th. Four investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $70.39.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.